BSE filing, NSE: WONDERLA. Summary written from the filing by ALFA Finder's alert engine.
Wonderla Holidays Ltd: key numbers
- Share price
- ₹476.05
- Market cap
- ₹3,021 Cr
- Revenue (annual)
- ₹518.8 Cr
- Net profit (annual)
- ₹81.73 Cr
- P/E (TTM)
- 29.6×Sector 34.0×
- Promoter holding
- 62.21%-0.01% QoQ
- FII holding
- 3.76%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Wonderla Holidays Ltd
All →Wonderla Holidays Board Meeting Date
Wonderla Holidays convened a board meeting scheduled for 02 Nov 2026 to approve Q1 FY27 unaudited results. No financial figures disclosed in this advance intimation.
Wonderla Holidays Legal & Regulatory
Wonderla Holidays received a GST Show Cause Notice demanding ₹34.28 Crore (inclusive of tax, interest, and penalty). The company is evaluating the notice and will respond.
- Value
- ₹34.28 Cr
Wonderla Holidays Credit Rating
Wonderla Holidays Ltd received a credit rating update from CARE Ratings, reaffirming ratings and revising the outlook for certain long-term facilities.
Wonderla Holidays Annual General Meeting
Wonderla Holidays Limited held its 24th Annual General Meeting on August 19, 2026. Shareholders approved a final dividend of Rs. 2.00 per equity share for FY 2025-26.
Wonderla Holidays Earnings Call Transcript: Key Takeaways
Wonderla reported record Q1 FY27 results with 41% revenue growth driven by the Chennai park scale-up and strong footfalls across existing locations.
Wonderla Holidays Investor Presentation: Key Takeaways
Q1 FY27 revenue grew 44.2% YoY to Rs. 24,263 lakhs, driven by record resort performance and the addition of Chennai Park.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.